100,000 Genomes Project hits half way mark

21 Feb 2018, 4:02 p.m.

The pioneering 100,000 Genomes Project has reached the 50,000 genomes landmark. It’s a milestone that has only been made possible through the generous participation of tens of thousands of patients and their families, including 1,492 GOSH families.The project aims to sequence 100,000 genomes from around 70,000 people to help doctors better understand, and ultimately treat, rare and inherited diseases and various cancers.

Great Ormond Street Hospital (GOSH) leads the North Thames Genomic Medicine Centre, one of 13 regional centres which are responsible for coordinating recruitment of more than 100 patients a month. So far 12,315 genomes have been collected by the North Thames Genomic Medicine Centre including 4,142 genomes collected at GOSH and 1,492 GOSH families recruited.

In 2016 GOSH patients Georgia and Jessica were the first to receive a genetic diagnosis as part of the 100,000 Genomes Project. For patients with rare diseases, a diagnosis can remove a large amount of uncertainty for the families, often after many years of distress. The results can have a major impact on many areas of patient lives including future treatment options, social support and family planning. They also have the potential to help many more children with undiagnosed conditions who may be tested for these genetic mutations early on and be offered a diagnosis to help manage their condition most effectively.

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Update for patients and families on industrial action - December 2025

As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Wednesday 17 December to 7am on Monday 22 December.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer